Document is current
Any future updates will be listed below
-
Authors
Otsuka, Takashi
Yamagata, Kaoru
Nguyen, Mai-Phuong
Ngo, Uyen Thi
Sakai, Hidenori
Trimova, Gulzhan
Anan, Junpei
Okada, Yosuke
Nakayamada, Shingo
Tanaka, Yoshiya https://orcid.org/0000-0002-0807-7139
-
Funding
Funding for this research was provided by:
Consejería de Educación, Universidades, Cultura y Deportes, Gobierno de Canarias (JSPS KAKENHI #19K08925)
Health Promotion Administration, Ministry of Health and Welfare
Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail
- License Information
-
More Information
Article History
Received: 11 November 2024
Accepted: 15 March 2025
First Online: 10 April 2025
Declarations
:
: Not applicable.
: Not applicable.
: S. Nakayamada has received consulting fees, speaking fees, lecture fees, and/or honoraria from AstraZeneca, GlaxoSmithKline, Pfizer, Bristol-Myers, Astellas, Asahi-kasei, AbbVie, Chugai, Sanofi, Eisai, Gilead Sciences, Mitsubishi-Tanabe, Janssen, Eli Lilly, Boehringer Ingelheim, and Ayumi. Y. Okada has received lecture fees from AstraZeneca, MSD, Ono, Mitsubishi-Tanabe, Bayer, Novo Nordisk, Eli Lilly, and Boehringer Ingelheim and research funds from Kowa and Mitsubishi-Tanabe. Y. Tanaka has received speaking fees and/or honoraria from Abbvie, Eisai, Chugai, Eli-Lilly, Behringer-Ingelheim, GlaxoSmithKline, Taisho, AstraZeneca, Daiichi-Sankyo, Gilead, Pfizer, UCB, Asahi-kasei, and Astellas and received research grants from Behringer-Ingelheim, Taisho, and Chugai. The other authors declare that they have no competing interests.
